Integrum AB Series B
Integrum AB (publ) researches, develops, and sells various systems for bone-anchored prostheses. The company provides prostheses for the Rehabilitation of Amputees (OPRA) implant systems, a bone-anchored prostheses system based on osseointegration, where the prostheses are directly attached to the bone, avoiding the use of socket. The OPRA implant system offers protection to the patient by avoidi… Read more
Integrum AB Series B (INTEG-B) - Total Liabilities
Latest total liabilities as of September 2025: Skr22.09 Million SEK
Based on the latest financial reports, Integrum AB Series B (INTEG-B) has total liabilities worth Skr22.09 Million SEK as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Integrum AB Series B - Total Liabilities Trend (2013–2024)
This chart illustrates how Integrum AB Series B's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Integrum AB Series B Competitors by Total Liabilities
The table below lists competitors of Integrum AB Series B ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
CRTUF
PINK:CRTUF
|
USA | $12.88 Million |
|
Advance Metals Ltd
AU:AVM
|
Australia | AU$379.29K |
|
Profoto Holding AB
ST:PRFO
|
Sweden | Skr453.00 Million |
|
RP Optical Lab Ltd
TA:RPOL
|
Israel | ₪14.82 Million |
|
Biomind Labs Inc.
PINK:BMNDF
|
USA | $1.62 Million |
|
ReVolve Renewable Power Corp.
OTCQB:REVVF
|
USA | $11.99 Million |
|
Burgundy Diamond Mines Ltd
AU:BDM
|
Australia | AU$723.12 Million |
|
Iris Business Services Limited
NSE:IRIS
|
India | ₹611.02 Million |
Liability Composition Analysis (2013–2024)
This chart breaks down Integrum AB Series B's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.44 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.14 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.12 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Integrum AB Series B's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Integrum AB Series B (2013–2024)
The table below shows the annual total liabilities of Integrum AB Series B from 2013 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | Skr25.38 Million | +14.98% |
| 2023-12-31 | Skr22.07 Million | +2.01% |
| 2022-12-31 | Skr21.64 Million | +4.55% |
| 2021-12-31 | Skr20.70 Million | +60.25% |
| 2020-12-31 | Skr12.91 Million | +52.49% |
| 2019-12-31 | Skr8.47 Million | -4.33% |
| 2018-12-31 | Skr8.85 Million | +5.65% |
| 2017-12-31 | Skr8.38 Million | -9.31% |
| 2016-12-31 | Skr9.24 Million | +2.27% |
| 2015-12-31 | Skr9.03 Million | +71.03% |
| 2014-12-31 | Skr5.28 Million | -5.99% |
| 2013-12-31 | Skr5.62 Million | -- |